Research
Hormonal
Mitochondrial fusion in specific hypothalamic neurons (NPY/Agrp and POMC) regulates energy balance, where impaired fusion in these neurons can lead to resistance to diet-induced obesity or leptin resistance.
Mitochondrial health in the brain plays a role in how your body regulates hunger and stores fat. Disruptions in mitochondrial fusion in specific brain neurons may contribute to obesity and leptin resistance.
ModerateQualifiesMEDIUM confidence
During positive energy balance (high fat diet exposure) in mice, mitochondrial fusion increased in orexigenic NPY/Agrp neurons to enable elevated neuronal activity and maximize storage of excess energy in fat.
Why this rating
Based on mouse knockout studies and reviews; direct human application is less clear.
Source
Diet impact on mitochondrial bioenergetics and dynamics
Rosalba Putti et al. · Frontiers in Physiology · 2015
DOI 10.3389/fphys.2015.00109
narrative_reviewCited 189×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- High-fat diets rich in saturated fatty acids (e.g., lard) induce mitochondrial fission and dysfunction in liver and skeletal muscle, whereas diets rich in omega-3 polyunsaturated fatty acids (e.g., fish oil) promote mitochondrial fusion and improve function.Good
- Caloric restriction (CR) increases mitochondrial fission proteins and biogenesis to maintain ATP levels and reduce oxidative stress, contributing to longevity, whereas starvation induces mitochondrial fusion to protect against degradation.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →